Vista Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sales

10.29

1.00

0.39

1.27

22.76

Operating profit

-3.57

-2.22

-1.21

-1.73

-4.80

Interest

1.22

1.21

0.90

1.55

1.54

Gross profit

-4.46

-3.15

-1.94

-2.96

-2.59

EPS (Rs)

-0.96

-1.58

-0.23

-0.51

-1.21

Other income

0.33

0.29

0.17

0.32

3.75

Stock adjustment

0.01

-

-

-

1.04

Raw material

8.88

1.23

0.37

0.73

22.90

Power and fuel

-

-

-

-

-

Employee expenses

1.79

0.58

0.57

1.15

1.49

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

3.17

1.41

0.66

1.11

2.13

Provisions made

-

-

-

-

-

Depreciation

0.72

1.57

0.62

0.73

1.35

Taxation

-0.67

1.09

-1.73

-1.80

-0.26

Net profit / loss

-4.51

-5.82

-0.83

-1.89

-3.68

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

9.43

7.36

7.36

7.36

6.07

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

-34.71

-221.31

-306.77

-136.58

-21.08

GPM (%)

-41.97

-244.28

-347.06

-186.77

-9.77

NPM (%)

-42.48

-451.22

-148.46

-118.95

-13.87